Jean-yves Bonnefoy
president
Biochemistry
Oncodesign
France
Biography
Jean-Yves Bonnefoy, PhD, is an immunologist. He held management positions for over 20 years at GSK, Pierre Fabre and then Transgene. He also initiated and ran the cancer centre of excellence Cancéropôle Lyon Rhône-Alpes from 2002 to 2005. Jean-Yves Bonnefoy is currently President & CEO of Anagenesis Biotechnologies, member of the investment committee of the TTO Conectus Alsace and of the steering committee of Matwin, member of the scientific advisory boards of iTeos Therapeutics and Centre de Recherche des Cordeliers, and President of Syndivia. He is the author or co-author of over 230 peer-reviewed scientific articles and reviews.
Research Interest
Biochemistry, chemistry, immunology
